Table 1.

Distribution of plasma miR-21 and miR-92a levels across the study population

The study population	Cases (N)	Plasma miR-21 levels (Median & range; Fold changes)	Plasma miR-92a levels (Median & range; Fold changes)
Healthy controls	30	1.22 (0.39 -1.92)	1.23 (0.04 - 1.66)
IBS	30	1.24 (0.39 - 1.94)	1.22 (0.06 - 1.63)
UC	37	1.85 (0.85 - 5.10)	2.48 (1.57 - 12.91)
CRC	33	38.59 (1.67 - 103552.29)	195.3610 (0.21 - 30362.43)

CRC: colorectal cancer; IBS: irritable bowel syndrome; UC: ulcerative colitis